Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€14.04

€14.04

-7.950%
-1.205
-7.950%
-

-

 
01.12.21 / Tradegate WKN: A1J5U0 / Name: Intercept / Stock / Biotechnology & Medical Research / Small Cap /

Intercept Pharmaceuticals Stock

Heavy losses for Intercept Pharmaceuticals today as the stock fell by -€1.205 (-7.950%).
For the coming years our community has positive and negative things to say abot the Intercept Pharmaceuticals stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.

Pros and Cons of Intercept Pharmaceuticals in the next few years

Pros
0
-
Cons
1
Probably not worthwhile Investment

Performance of Intercept Pharmaceuticals vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Intercept Pharmaceuticals -7.950% -5.869% -15.958% -51.520% -29.930% -85.660% -85.148%
Clovis Oncology Inc. 3.000% -15.087% -39.075% -45.444% -33.141% -85.185% -92.773%
Aveo Pharmaceuticals Inc. -1.380% -17.452% -24.199% 6.292% 5.935% -75.105% -22.964%
Epizyme Inc. -3.170% -10.477% -23.900% -73.982% -70.073% - -

Comments

Buy Intercept Pharmaceuticals
Show more

Buy Intercept Pharmaceuticals
Show more

Sell Intercept Pharmaceuticals
Show more

Other discussions about Intercept Pharmaceuticals Stock

Trading Intercept Pharmaceuticals

Trading Intercept Pharmaceuticals

New thread Forum